Pasar al contenido principal

ORGANIZACION DINAMICA 3D DE LA CROMATINA EN LA HEMATOPOYESIS HUMANA: DESCRIPCION DE NUEVOS GENES ASOCIADOS A ENFERMEDADES HEMATOLOGICAS

RTI2018-094788-A-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte development

  • Azagra, Alba
  • Meler, Ainara
  • Barrios, Oriol de
  • Tomás-Daza, Laureano
  • Collazo, Olga
  • Monterde, Beatriz
  • Obiols, Mireia
  • Rovirosa, Llorenç
  • Vila-Casadesús, Maria
  • Cabrera-Pasadas, Mónica
  • Gusi-Vives, Mar
  • Graf, Thomas
  • Varela, Ignacio
  • Sardina, José Luis
  • Javierre, Biola M.
  • Parra, Maribel
Correct B cell identity at each stage of cellular differentiation during B lymphocyte development is critically dependent on a tightly controlled epigenomic landscape. We previously identified HDAC7 as an essential regulator of early B cell development and its absence leads to a drastic block at the pro-B to pre-B cell transition. More recently, we demonstrated that HDAC7 loss in pro-B-ALL in infants associates with a worse prognosis. Here we delineate the molecular mechanisms by which HDAC7 modulates early B cell development. We find that HDAC7 deficiency drives global chromatin de-condensation, histone marks deposition and deregulates other epigenetic regulators and mobile elements. Specifically, the absence of HDAC7 induces TET2 expression, which promotes DNA 5-hydroxymethylation and chromatin de-condensation. HDAC7 deficiency also results in the aberrant expression of microRNAs and LINE-1 transposable elements. These findings shed light on the mechanisms by which HDAC7 loss or misregulation may lead to B cell-based hematological malignancies., Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2017-87990-R]; Spanish Ministry of Science and Innovation (MICINN) [EUR2019-103835]; Josep Carreras Leukemia Research Institute (IJC, Badalona, Barcelona); IDIBELL Research Institute (L’Hospitalet de Llobregat, Barcelona); A.M. is funded by the Spanish Ministry of Science, Innovation and Universities, which is part of the Agencia Estatal de Investigacion (AEI) [PRE2018-083183] (cofunded by the European Social Fund]; OdB. was funded by a Juan de la Cierva Formacion Fellowship ´ from the Spanish Ministry of Science, Innovation and Universities [FJCI-2017-32430]; Postdoctoral Fellowship from the Asociacion Espa ´ nola Contra el C ˜ ancer (AECC) ´ Foundation [POSTD20024DEBA]; B.M. is awardee of the Ayudas para la formacion del profesorado universitario ´[FPU18/00755, Ministerio de Universidades]; B.M.J. is funded by La Caixa Banking Foundation Junior Leader project [LCF/BQ/PI19/11690001]; FEDER/Spanish Ministry of Science and Innovation [RTI2018-094788-A-I00]; L.T.-D. is funded by the FPI Fellowship [PRE2019-088005]; L.R. is funded by an AGAUR FI fellowship [2019FI-B00017]; J.L.S. is funded by ISCIII [CP19/00176], co-funded by ESF, ‘Investing in your future’ and the Spanish Ministry of Science, Innovation and Universities [PID2019-111243RA-I00]. CRG acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049- S, MCIN/AEI /10.13039/501100011033). Funding for open access charge: Spanish Ministry of Science, Innovation and Universities (MICIU) [SAF2017-87990-R, EUR2019-103835]. With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001049-S)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

The Genome in a Three-Dimensional Context, Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer

  • Rovirosa Mulet, Llorenç|||0000-0003-2986-9001
  • Ramos-Morales, Alberto|||0000-0002-6355-0136
  • Javierre, B. M.|||0000-0002-8682-6748
Associations between blood cancer and genetic predisposition, including both inherited variants and acquired mutations and epimutations, have been well characterized. However, the majority of these variants affect noncoding regions, making their mechanisms difficult to hypothesize and hindering the translation of these insights into patient benefits. Fueled by unprecedented progress in next-generation sequencing and computational integrative analysis, studies have started applying combinations of epigenetic, genome architecture, and functional assays to bridge the gap between noncoding variants and blood cancer. These complementary tools have not only allowed us to understand the potential malignant role of these variants but also to differentiate key variants, cell-types, and conditions from misleading ones. Here, we briefly review recent studies that have provided fundamental insights into our understanding of how noncoding mutations at enhancers predispose and promote blood malignancies in the context of spatial genome architecture.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease

  • Watt, Stephen
  • Vasquez, Louella|||0000-0002-5758-6036
  • Walter, Klaudia|||0000-0003-4448-0301
  • Mann, Alice L.|||0000-0003-2402-8545
  • Kundu, Kousik|||0000-0002-1019-8351
  • Chen, Lu
  • Sims, Ying|||0000-0003-4765-4872
  • Ecker, Simone|||0000-0001-5648-1710
  • Burden, Frances
  • Farrow, Samantha
  • Farr, Ben
  • Iotchkova, Valentina|||0000-0001-5057-0210
  • Elding, Heather
  • Mead, Daniel|||0000-0001-7717-4330
  • Tardaguila, Manuel|||0000-0001-7812-604X
  • Ponstingl, Hannes|||0000-0001-7573-1703
  • Richardson, David|||0000-0003-0247-9118
  • Datta, Avik|||0000-0002-1411-8638
  • Flicek, Paul|||0000-0002-3897-7955
  • Clarke, Laura|||0000-0002-5989-6898
  • Downes, Kate
  • Pastinen, Tomi
  • Fraser, Peter|||0000-0002-0041-1227
  • Frontini, Mattia
  • Javierre, B. M.|||0000-0002-8682-6748
  • Spivakov, Mikhail|||0000-0002-0383-3943
  • Soranzo, Nicole|||0000-0003-1095-3852
Neutrophils play fundamental roles in innate immune response, shape adaptive immunity, and are a potentially causal cell type underpinning genetic associations with immune system traits and diseases. Here, we profile the binding of myeloid master regulator PU.1 in primary neutrophils across nearly a hundred volunteers. We show that variants associated with differential PU.1 binding underlie genetically-driven differences in cell count and susceptibility to autoimmune and inflammatory diseases. We integrate these results with other multi-individual genomic readouts, revealing coordinated effects of PU.1 binding variants on the local chromatin state, enhancer-promoter contacts and downstream gene expression, and providing a functional interpretation for 27 genes underlying immune traits. Collectively, these results demonstrate the functional role of PU.1 and its target enhancers in neutrophil transcriptional control and immune disease susceptibility.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High-resolution simulations of chromatin folding at genomic rearrangements in malignant B cells provide mechanistic insights into proto-oncogene deregulation

  • Rico, Daniel|||0000-0002-6561-2310
  • Kent, Daniel
  • Karataraki, Nefeli
  • Mikulasova, Aneta
  • Berlinguer-Palmini, Ronaldo
  • Walker, Brian A.
  • Javierre, B. M|||0000-0002-8682-6748
  • Russell, Lisa J.
  • Brackley, Chris A.
Genomic rearrangements are known to result in proto-oncogene deregulation in many cancers, but the link to 3D genome structure remains poorly understood. Here, we used the highly predictive heteromorphic polymer (HiP-HoP) model to predict chromatin conformations at the proto-oncogene CCND1 in healthy and malignant B cells. After confirming that the model gives good predictions of Hi-C data for the nonmalignant human B cell-derived cell line GM12878, we generated predictions for two cancer cell lines, U266 and Z-138. These possess genome rearrangements involving CCND1 and the immunoglobulin heavy locus (IGH), which we mapped using targeted genome sequencing. Our simulations showed that a rearrangement in U266 cells where a single IGH super-enhancer is inserted next to CCND1 leaves the local topologically associated domain (TAD) structure intact. We also observed extensive changes in enhancer-promoter interactions within the TAD, suggesting that it is the downstream chromatin remodeling which gives rise to the oncogene activation, rather than the presence of the inserted super-enhancer DNA sequence per se. Simulations of the IGH-CCND1 reciprocal translocation in Z-138 cells revealed that an oncogenic fusion TAD is created, encompassing CCND1 and the IGH super-enhancers. We predicted how the structure and expression of CCND1 changes in these different cell lines, validating this using qPCR and fluorescence in situ hybridization microscopy. Our work demonstrates the power of polymer simulations to predict differences in chromatin interactions and gene expression for different translocation breakpoints.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution

  • Tomás Daza, Laureano|||0000-0002-6127-1694
  • Rovirosa Mulet, Llorenç|||0000-0003-2986-9001
  • López-Martí, Paula
  • Nieto-Aliseda, Andrea|||0000-0002-3238-8711
  • Serra, François|||0000-0003-3895-4742
  • Planas-Riverola, Ainhoa
  • Molina, Oscar|||0000-0001-7585-4519
  • McDonald, Rebecca|||0000-0002-6131-1748
  • Ghevaert, Cedric
  • Cuatrecasas, Esther|||0000-0003-2881-4412
  • Costa, Dolors|||0000-0002-8276-3292
  • Camós, Mireia|||0000-0003-3658-7942
  • Bueno, Clara|||0000-0003-1442-6216
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Valencia, Alonso
  • Javierre, B. M.|||0000-0002-8682-6748
Long-range interactions between regulatory elements and promoters are key in gene transcriptional control; however, their study requires large amounts of starting material, which is not compatible with clinical scenarios nor the study of rare cell populations. Here we introduce low input capture Hi-C (liCHi-C) as a cost-effective, flexible method to map and robustly compare promoter interactomes at high resolution. As proof of its broad applicability, we implement liCHi-C to study normal and malignant human hematopoietic hierarchy in clinical samples. We demonstrate that the dynamic promoter architecture identifies developmental trajectories and orchestrates transcriptional transitions during cell-state commitment. Moreover, liCHi-C enables the identification of disease-relevant cell types, genes and pathways potentially deregulated by non-coding alterations at distal regulatory elements. Finally, we show that liCHi-C can be harnessed to uncover genome-wide structural variants, resolve their breakpoints and infer their pathogenic effects. Collectively, our optimized liCHi-C method expands the study of 3D chromatin organization to unique, low-abundance cell populations, and offers an opportunity to uncover factors and regulatory networks involved in disease pathogenesis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte development

  • Azagra, Alba|||0000-0002-9097-1251
  • Meler, Ainara|||0000-0002-0026-7325
  • de Barrios, Oriol|||0000-0001-5076-1455
  • Tomás Daza, Laureano|||0000-0002-6127-1694
  • Collazo, Olga
  • Monterde, B.
  • Obiols, Mireia|||0000-0003-3323-5239
  • Rovirosa Mulet, Llorenç|||0000-0003-2986-9001
  • Vila-Casadesús, Maria|||0000-0001-6597-7953
  • Cabrera Pasadas, Mònica|||0000-0001-9216-0906
  • Gusi Vives, Mar|||0000-0001-5702-153X
  • Graf, Thomas|||0000-0003-2774-4117
  • Varela, Ignacio|||0000-0002-0969-506X
  • Sardina, José Luis|||0000-0002-8493-3937
  • Javierre, B. M.|||0000-0002-8682-6748
  • Parra, Maribel|||0000-0002-9072-5763
Correct B cell identity at each stage of cellular differentiation during B lymphocyte development is critically dependent on a tightly controlled epigenomic landscape. We previously identified HDAC7 as an essential regulator of early B cell development and its absence leads to a drastic block at the pro-B to pre-B cell transition. More recently, we demonstrated that HDAC7 loss in pro-B-ALL in infants associates with a worse prognosis. Here we delineate the molecular mechanisms by which HDAC7 modulates early B cell development. We find that HDAC7 deficiency drives global chromatin de-condensation, histone marks deposition and deregulates other epigenetic regulators and mobile elements. Specifically, the absence of HDAC7 induces TET2 expression, which promotes DNA 5-hydroxymethylation and chromatin de-condensation. HDAC7 deficiency also results in the aberrant expression of microRNAs and LINE-1 transposable elements. These findings shed light on the mechanisms by which HDAC7 loss or misregulation may lead to B cell-based hematological malignancies.